Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,343.72
(
-0.39%
)
US TECH 100
22,228.00
(
-1.22%
)
Dow Jones
45,216.14
(
0.11%
)
Brent Oil
109.52
(
0.88%
)
Bitcoin
66,608.50
(
-0.14%
)
News Focus
News Focus
Post# of 257313
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122824
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: Bickema post# 198964

Monday, 01/11/2016 1:08:06 PM

Monday, January 11, 2016 1:08:06 PM

Post# of 257313
EGRX—Slides #5 and #18 show a new undisclosed (presumably 505b2) program to reduce the frequency of injections in a currently-approved drug generating $400M in annual US sales. (These slides also refer to the AMRI collaboration announced today.)

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today